Malbinder Fagura

Speaker Bio

I lead purpose-driven partnerships with healthcare systems to redesign care pathways; using AI and evidence-based innovation to reduce time to diagnosis and tackle healthcare inequities at scale. My focus is simple: bring innovations, clinicians, academics, and communities together to co-create solutions that improve patient outcomes and make best practice the norm, not the exception.

I’ve partnered across MedTech, clinical and academic teams to design, validate, and implement new models of care that deliver measurable impact and are built to spread and scale. The result: faster, earlier diagnosis and more equitable access to high-quality care.

Right now, I’m focused on transforming global care for cardiac amyloidosis; co-leading AstraZeneca's ACT on Amyloidosis program to enable earlier diagnosis, accelerate referral to specialist care, and improve outcomes for patients worldwide.